NCT05144022

Brief Summary

Although it is well known that stress plays an important role in the development of neuropsychiatric diseases, the precise role and molecular effects of stress have only been poorly understood. For example, autophagy is essential for energy and cellular homeostasis through protein catabolism, and dysregulation results in compromised proteostasis, stress-coping behavior, and excessive secretion of signaling molecules and inflammatory factors. Therefore, the aim of the project is to analyze the clinical effects of a bungee jump resembling an acute stress event in correlation to autophagy and other underlying, multi-level molecular profiling. Specifically, it is planned to perform multi-level molecular profiling and sleep analysis in a cohort of healthy male individuals before, during, and after a bungee jump compared to a control cohort of healthy males not undergoing a stress event. The resulting findings will advance the role of autophagy during the stress response and hence in the development of psychiatric disorders, and possibly investigate alternative treatment venues on a molecular level, and finally contribute to a better clinical outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

4 months

First QC Date

October 27, 2021

Last Update Submit

November 9, 2022

Conditions

Keywords

StressBungee JumpAutophagy

Outcome Measures

Primary Outcomes (1)

  • Proteomics and autophagy processes

    Change in protein levels of autophagy biomarkers (LC3II \& p62) of isolated PBMCs (peripheral blood mononuclear cells) by Western Blotting.

    change from baseline to the stress intervention and a 5- 7 day follow up

Secondary Outcomes (11)

  • Proteome patterns

    change from baseline to the stress intervention and a 5- 7 day follow up

  • Metabolic processes

    change from baseline to the stress intervention and a 5- 7 day follow up

  • Lipid profiling

    change from baseline to the stress intervention and a 5- 7 day follow up

  • Saliva Cortisol Levels

    comparison between groups

  • Sleep Efficiency

    change from baseline to the stress intervention and a 5- 7 day follow up

  • +6 more secondary outcomes

Study Arms (2)

Interventions group: High stress condition (bungee jump)

EXPERIMENTAL

25-30 healthy male volunteers participating in a bungee jump

Behavioral: Bungee jump

Control group: No stress condition

PLACEBO COMPARATOR

10-15 healthy males serving as a control group without undergoing a stress event/intervention

Behavioral: Bungee jump

Interventions

Bungee jumpBEHAVIORAL

Bungee jump from a cran

Control group: No stress conditionInterventions group: High stress condition (bungee jump)

Eligibility Criteria

Age20 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Present written declaration of consent
  • Healthy
  • Male
  • BMI between 18,5 and 24,9 and body weight between 50kg and 120kg

You may not qualify if:

  • Insufficient linguistic communication
  • Drug abuse or alcohol dependency
  • regular medication except for L-thyroxine or antihistamines
  • known severe eye disease or severely impaired eyesight or hearing
  • a known disease of the cardiovascular system, hypertension higher than 160/90mmHg
  • known pulmonary disease, e.g. bronchial asthma
  • known fractures of the spine or skeletal system of the lower extremity
  • surgery within the last 4 to six months
  • intervention group: fear of heights

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Bonn, Clinic for psychiatry and psychotherapy

Bonn, 53111, Germany

Location

Related Publications (9)

  • Ayash S, Schmitt U, Lyons DM, Muller MB. Stress inoculation in mice induces global resilience. Transl Psychiatry. 2020 Jun 19;10(1):200. doi: 10.1038/s41398-020-00889-0.

    PMID: 32561821BACKGROUND
  • Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017 May 5;18(1):83. doi: 10.1186/s13059-017-1215-1.

    PMID: 28476144BACKGROUND
  • Hennig J, Laschefski U, Opper C. Biopsychological changes after bungee jumping: beta-endorphin immunoreactivity as a mediator of euphoria? Neuropsychobiology. 1994;29(1):28-32. doi: 10.1159/000119059.

    PMID: 8127421BACKGROUND
  • Klein EM, Brahler E, Dreier M, Reinecke L, Muller KW, Schmutzer G, Wolfling K, Beutel ME. The German version of the Perceived Stress Scale - psychometric characteristics in a representative German community sample. BMC Psychiatry. 2016 May 23;16:159. doi: 10.1186/s12888-016-0875-9.

    PMID: 27216151BACKGROUND
  • de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005 Jun;6(6):463-75. doi: 10.1038/nrn1683.

    PMID: 15891777BACKGROUND
  • Leistner C, Menke A. How to measure glucocorticoid receptor's sensitivity in patients with stress-related psychiatric disorders. Psychoneuroendocrinology. 2018 May;91:235-260. doi: 10.1016/j.psyneuen.2018.01.023. Epub 2018 Feb 2.

    PMID: 29449045BACKGROUND
  • Lyons DM, Parker KJ, Katz M, Schatzberg AF. Developmental cascades linking stress inoculation, arousal regulation, and resilience. Front Behav Neurosci. 2009 Sep 18;3:32. doi: 10.3389/neuro.08.032.2009. eCollection 2009.

    PMID: 19826626BACKGROUND
  • Nicora G, Vitali F, Dagliati A, Geifman N, Bellazzi R. Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools. Front Oncol. 2020 Jun 30;10:1030. doi: 10.3389/fonc.2020.01030. eCollection 2020.

    PMID: 32695678BACKGROUND
  • van Westerloo DJ, Choi G, Lowenberg EC, Truijen J, de Vos AF, Endert E, Meijers JC, Zhou L, Pereira MP, Queiroz KC, Diks SH, Levi M, Peppelenbosch MP, van der Poll T. Acute stress elicited by bungee jumping suppresses human innate immunity. Mol Med. 2011 Mar-Apr;17(3-4):180-8. doi: 10.2119/molmed.2010.00204. Epub 2010 Dec 10.

    PMID: 21203694BACKGROUND

Study Officials

  • Nils Gassen, Dr. rer. nat.

    University Hospital, Bonn

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: 2 groups each undergoing one out of two conditions ("high stress" (bungee jump) or "no stress" (control))
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 27, 2021

First Posted

December 3, 2021

Study Start

September 1, 2021

Primary Completion

January 1, 2022

Study Completion

January 1, 2023

Last Updated

November 10, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations